4114 fundamentals
SYNMOSA BIOPHARMA CORP revenue breakdown overview
The greatest contribution to the revenue figure was made by Taiwan — last year it brought SYNMOSA BIOPHARMA CORP 4.76 B TWD, and the year before that — 4.37 B TWD.
By source
2005
2006
2007
2008
2009
2010
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
1.50 B
3.00 B
4.50 B
6.00 B
Generic Drugs
Active Pharmaceutical Ingredients
Sales
Service
Pharmaceutical Products
Currency: TWD
2005
2006
2007
2008
2009
2010
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Generic Drugs
2.92 B
3.15 B
4.24 B
4.96 B
5.40 B
Active Pharmaceutical Ingredients
115.98 M
88.44 M
147.98 M
179.59 M
153.01 M
Sales
—
—
—
—
—
Service
—
—
—
—
—
Pharmaceutical Products
—
—
—
—
—
By country
2005
2006
2007
2008
2009
2010
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
0.00
1.50 B
3.00 B
4.50 B
6.00 B
Taiwan
China
Singapore
Malaysia
Thailand
United States
Canada
Other
Hong Kong
Currency: TWD
2005
2006
2007
2008
2009
2010
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Taiwan
2.62 B
2.81 B
3.88 B
4.37 B
4.76 B
China
301.67 M
293.58 M
271.73 M
534.01 M
564.55 M
Singapore
—
—
—
41.91 M
75.89 M
Malaysia
19.09 M
19.41 M
30.75 M
36.45 M
34.36 M
Thailand
25.88 M
23.16 M
39.60 M
54.56 M
29.70 M
United States
—
—
62.74 M
28.78 M
2.21 M
Canada
—
30.29 M
34.97 M
15.50 M
2.14 M
Other
72.75 M
55.13 M
70.10 M
60.80 M
79.11 M
Hong Kong
—
—
—
—
—